Skip to search.
 FTSE 100 Up 1.16%

BIND Therapeutics, Inc. (BIND)

-NasdaqGS
5.05 Down 0.13(2.51%) 29 Jul 21:00
Add to Portfolio
Prev Close:5.18
Open:5.21
Bid:4.85 x 1000
Ask:5.51 x 200
1y Target Est:17.33
Beta:N/A
Next Earnings Date: 6-Aug-15BIND Earnings announcement
Day's Range:5.02 - 5.25
52wk Range:4.89 - 10.78
Volume:60,478
Avg Vol (3m):155,094
Market Cap:102.99m
P/E (ttm):N/A
EPS (ttm):-1.90
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BINDDown 2.51%102.99m
BMYUp 0.36%108.20b
PGNXDown 10.51%587.11m

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.95
Quarterly EPS Est (Jun-15) :-0.51
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company, develops various targeted and programmable therapeutics. It is developing Accurins that are designed with specific pharmaceutical characteristics intended to target tumors at... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback